An in Silico Scientific Basis for LL-37 as a Therapeutic and Vitamin D as Preventive for Covid-19 (preprint)

A multi-pronged approach with help in all forms possible is essential to completely overcome the Covid-19 pandemic There is a requirement to research as many new and different types of approaches as possible to cater to the entire world population, complementing the vaccines with promising results The need is also because SARS-CoV-2 has several unknown or variable facets which get revealed from time to time In this report, in silico scientific findings are presented, which are indicative of the potential for the use of the LL-37 human anti-microbial peptide as a therapeutic against SARS-CoV-2 This indication is based on the high structural similarity of LL-37 to the N-terminal helix, with which the virus interacts, of the receptor for SARS-CoV-2, Angiotensin Converting Enzyme 2 Moreover, there is positive prediction of binding of